UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B

Journal of hepatology, 2013-02, Vol.58 (2), p.225-233

2013

Volltextzugriff (PDF)

Virological Treatment Monitoring for Chronic Hepatitis B

Viruses, 2022-06, Vol.14 (7), p.1376

2022

Volltextzugriff (PDF)

Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature

World journal of gastroenterology : WJG, 2016-09, Vol.22 (35), p.8010-8016

2016

Volltextzugriff (PDF)

Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods

PloS one, 2017-11, Vol.12 (11), p.e0187755

2017

Volltextzugriff (PDF)

Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment

Annals of hepatology, 2018, Vol.17 (1), p.64-75

2018

Volltextzugriff (PDF)

Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels

PloS one, 2013-06, Vol.8 (6), p.e65327-e65327

2013

Volltextzugriff (PDF)

Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis:a systematic review and meta-analysis

World journal of hepatology, 2017-02, Vol.9 (6), p.333-342

2017

Volltextzugriff (PDF)

Host Ethnicity and Virus Genotype Shape the Hepatitis B Virus-Specific T-Cell Repertoire

Journal of Virology, 2008-11, Vol.82 (22), p.10986-10997

2008

Volltextzugriff (PDF)

HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts

PLoS medicine, 2007-03, Vol.4 (3), p.e96-e96

2007

Volltextzugriff (PDF)

Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C

Journal of clinical virology, 2013-03, Vol.56 (3), p.291-295

2013

Volltextzugriff (PDF)

Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B

Gastroenterology (New York, N.Y. 1943), 2010-02, Vol.138 (2), p.682-693.e4

2010

Volltextzugriff (PDF)

Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C： A phase Ⅱ study

World journal of gastroenterology : WJG, 2009-12, Vol.15 (47), p.5946-5952

2009

Volltextzugriff (PDF)

Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirin

Annals of hepatology, 2014-03, Vol.13 (2), p.196-203

2014

Volltextzugriff (PDF)

Managing HCV treatment failure and the potential of resistance testing in informing second-line therapy options

Expert review of anti-infective therapy, 2018-11, Vol.16 (11), p.833-838

2018

Volltextzugriff (PDF)

Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV

Gastroenterology (New York, N.Y. 1943), 2012-12, Vol.143 (6), p.1576-1585.e4

2012

Volltextzugriff (PDF)

Chronic hepatitis B: Are we close to a cure?

Digestive and liver disease, 2015-10, Vol.47 (10), p.836-841

2015

Volltextzugriff (PDF)

The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection

Prostaglandins & other lipid mediators, 2022-04, Vol.159, p.106619-106619, Article 106619

2022

Volltextzugriff (PDF)

Serum hepatitis B core‐related antigen is an effective tool to categorize patients with HBeAg‐negative chronic hepatitis B

Journal of viral hepatitis, 2019-05, Vol.26 (5), p.568-575

2019

Volltextzugriff (PDF)

FRI470 - Diagnostic performance of PIVKA-II in patients with hepatocellular carcinoma

Journal of hepatology, 2020-08, Vol.73, p.S631-S632

2020

Volltextzugriff (PDF)

Diagnostic performance of PIVKA-II in patients with hepatocellular carcinoma

Journal of hepatology, 2020-08, Vol.73, p.S631-S632

2020

Volltextzugriff (PDF)

The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis

Italian journal of medicine, 2013-03, Vol.5 (2), p.82-89

2013

Volltextzugriff (PDF)

Hepatitis B virus Reactivation among Hepatitis C Patients Treated with Direct-acting Antiviral Therapies in Routine Clinical Practice

Journal of clinical virology, 2017-08, Vol.93, p.66-70

2017

Volltextzugriff (PDF)

Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"

Journal of translational medicine, 2005-05, Vol.3 (1), p.20-20, Article 20

2005

Volltextzugriff (PDF)

SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses

Future microbiology, 2021-09, Vol.16 (14), p.1105-1133

2021

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(56)
Berichte
(1)

Sprache

Englisch
(57)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B

Virological Treatment Monitoring for Chronic Hepatitis B

Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature

Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods

Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment

Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels

Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis:a systematic review and meta-analysis

Host Ethnicity and Virus Genotype Shape the Hepatitis B Virus-Specific T-Cell Repertoire

HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts

Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C

Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B

Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C： A phase Ⅱ study

Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirin

Managing HCV treatment failure and the potential of resistance testing in informing second-line therapy options

Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV

Chronic hepatitis B: Are we close to a cure?

HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B

The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection

Serum hepatitis B core‐related antigen is an effective tool to categorize patients with HBeAg‐negative chronic hepatitis B

FRI470 - Diagnostic performance of PIVKA-II in patients with hepatocellular carcinoma

Diagnostic performance of PIVKA-II in patients with hepatocellular carcinoma

The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis

Hepatitis B virus Reactivation among Hepatitis C Patients Treated with Direct-acting Antiviral Therapies in Routine Clinical Practice

Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"

SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses

Suchergebnisse filtern